Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06157567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 6 of 6 sites
    v4
  2. Site contacts updated at 1 of 6 sitesv3
  3. Study description expanded, about 11 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a non-randomized, multi-center, open-label clinical trial evaluating clinical feasibility treatments with the Profound Matrix system.
Trial Details
NCT Number NCT06157567
Lead Sponsor Candela Corporation
Conditions
(from sponsor)		 Skin Laxity, Wrinkle, Skin Condition
Related terms Cutis Laxa, Skin Diseases
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov